<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541408</url>
  </required_header>
  <id_info>
    <org_study_id>Delirium</org_study_id>
    <nct_id>NCT03541408</nct_id>
    <nct_alias>NCT03591120</nct_alias>
  </id_info>
  <brief_title>Preventative Delirium Protocol in Elderly Patients</brief_title>
  <official_title>A Randomized, Controlled Trial Reviewing the Effectiveness of a Preventative Delirium Protocol in Elderly Patients While Analyzing Its Consequential Effects on Awareness, PONV, and/or Pain Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study aims to elucidate the effectiveness of a preventative delirium protocol in&#xD;
      patients older than 65 years of age undergoing elective surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A comprehensive analysis of patient specific risk factors and predisposing perioperative risk&#xD;
      factors will be completed. The objective is to see if delirium incidences are significantly&#xD;
      lower in the group that receives a preventative delirium protocol compared to a control&#xD;
      group, while not increasing other adverse undesirable side effects. We hypothesize that a&#xD;
      preventative delirium protocol will reduce the incidence of delirium compared to the control&#xD;
      group (primary outcome), but this protocol may lead to increased side effects such as PONV,&#xD;
      poor pain control, and increased awareness (secondary outcomes).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of Delirium (CAM_ICU)</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Delirium defined by Post-operative CAM, using the validated CAM-ICU measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Post-operative Nausea and Vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS Pain</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Numerical Rating Scale of Pain Intensity, 0 - 10 scale. Value of 0 is No Pain. Value of 10 is Worst Pain Imaginable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will receive anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preventative Delirium Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consider regional block if applicable&#xD;
Minimized fentanyl usage intraoperatively&#xD;
Intubation + GA adjunct total: 1-2 mcg/kg&#xD;
Sedation: 0-0.25 mcg/kg&#xD;
Post-op: 0.5-1 mcg/kg&#xD;
Avoid morphine&#xD;
Avoid ketamine&#xD;
Avoid diphenhydramine, dexamethasone, scopolamine, metoclopramide, and promethazine&#xD;
Avoid H2-blockers (cimetidine, ranitidine, famotidine)&#xD;
Avoid polypharmacy intraoperatively if possible (i.e. &gt;5 new medications)&#xD;
Fluid repletion based on maintenance and losses</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Standard Of Care without Preventative Delirium Protocol</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preventative Delirium Protocol</intervention_name>
    <description>Preventative Delirium Protocol</description>
    <arm_group_label>Preventative Delirium Protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 65 years&#xD;
&#xD;
          -  Scheduled for Elective Surgery (outpatient/same-day admit)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Need emergency surgery&#xD;
&#xD;
          -  Need intracranial surgery&#xD;
&#xD;
          -  Dependent on opiate narcotics&#xD;
&#xD;
          -  Surgeon-specified perioperative procedures that precludes the current study's protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asokumar Buvanendran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Asokumar Buvanendran</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

